Collaboration. Navigation. Innovation.
Early results from clinical study
Southlake Regional Health Centre is the leading Canadian research site for the first phase of the Foresight ICE trial.
“The Foresight ICE has provided us a new option for guiding trans-septal puncture and I see potential in the 3D imaging that we will be able to take advantage of in several EP and structural cases.”Dr. Atul Verma
Director Arrhythmia Services
Southlake Regional Health Centre
Conavi Medical Announces 510(k) Clearance
In 2015, we’re happy to announce that Conavi receives 510(k) clearance for their 3D Foresight ICE System™.
Conavi Welcomes New CEO
Conavi is pleased to announce that Murray Maynard has been appointed the Chief Executive Officer of the company, effective July 4th, 2016. Mr. Maynard has extensive experience in the cardiovascular device field, including sales, marketing, distribution, manufacturing, finance and board-level roles with several devices companies.
Early Results from Study
The Foresight ICE System, developed out of Sunnybrook Research Institute, is the focus of Southlake Regional Health Centre’s first phase of the Foresight ICE study. This study is looking at the first clinical use and efficacy of 2D forward and 3D intracardiac echocardiography to guide trans-septal punctures during AF ablation procedures. Several patients have already had successful trans-septal puncture supported by the use of the Foresight ICE system.
We have a new name
We have a new name, and a new look – Colibri Technologies is now Conavi Medical.
It's clear that there's a need. We have a path to get there.Dr. Brian Courtney